ID: ALA2408232

Max Phase: Preclinical

Molecular Formula: C21H14ClN3O2

Molecular Weight: 375.82

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1ccc(-c2ccc(-n3c(Cl)cc4[nH]c(=O)c(C#N)c(O)c43)cc2)cc1

Standard InChI:  InChI=1S/C21H14ClN3O2/c1-12-2-4-13(5-3-12)14-6-8-15(9-7-14)25-18(22)10-17-19(25)20(26)16(11-23)21(27)24-17/h2-10H,1H3,(H2,24,26,27)

Standard InChI Key:  CZDSKZBGMJONHZ-UHFFFAOYSA-N

Associated Targets(Human)

AMPK alpha2/beta2/gamma3 24 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

AMPK alpha2/beta2/gamma1 80 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

AMPK alpha1/beta2/gamma1 35 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

AMP-activated protein kinase (AMPK) alpha-1/beta-1/gamma-1 619 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Plasma 6361 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 375.82Molecular Weight (Monoisotopic): 375.0775AlogP: 4.52#Rotatable Bonds: 2
Polar Surface Area: 81.81Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 6.22CX Basic pKa: CX LogP: 4.02CX LogD: 2.82
Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.54Np Likeness Score: -0.96

References

1. Mirguet O, Sautet S, Clément CA, Toum J, Donche F, Marques C, Rondet E, Pizzonero M, Beaufils B, Dudit Y, Huet P, Trottet L, Grondin P, Brusq JM, Boursier E, Saintillan Y, Nicodeme E..  (2013)  Discovery of Pyridones As Oral AMPK Direct Activators.,  (7): [PMID:24900722] [10.1021/ml400157g]

Source